Company intelligence / Profile preview

Applikate Technologies

Washington, DC, United Statesapplikate.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Applikate’s automated histology platform enables direct-to-digital imaging of intact tissue specimens without physical slicing. Clinical studies have demonstrated its viability for primary diagnosis in prostate cancer, with ongoing validation for broader applications. The technology reduces processing time, cost, and risk of misdiagnosis while improving image quality and enabling global expert consultation.

Therapeutic areas: OncologyOther
Modalities: DeviceSoftware (Digital Imaging)
Industry: Pathology

Partnerships

National Cancer Institute / NIH SBIR grant supportCreative Destruction Lab business incubator

Beyond the preview

Go deeper on Applikate Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applikate Technologies.

Explore the full profile